Stocks and Investing
Stocks and Investing
Fri, February 22, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, February 21, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, February 20, 2019
[ 12:00 AM ] - United States, WOPRAI
Leah Cann Initiated (AGIO) at Hold on, Feb 20th, 2019
Leah Cann of Oppenheimer, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Hold on, Feb 20th, 2019.
Leah has made no other calls on AGIO in the last 4 months.
There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with Leah's Rating of Hold.
This is the rating of the analyst that currently disagrees with Leah
- Michael Schmidt of "Leerink Swann" Upgraded from Hold to Buy and Held Target at $80 on, Friday, February 15th, 2019
Contributing Sources